More PRNewswire
View Older Stories View Newer Stories-
re:BOND Hair Launches AMINOFIXX™ Daily Miracle Bond³ Building Spray - Advanced Solution for Hair Damage at the Molecular Level
-
Encompass Health and BSA Health System announce joint venture to own and operate rehabilitation hospital in Amarillo, Texas
-
Clinical Trial Application Success: CMC and Regulatory Insights from the US to Europe, Upcoming Webinar Hosted by Xtalks
-
Tie "James" Li, Chairman of NMHI, To Speak at XRP Seoul 2025 Global Conference
-
Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek®
-
Patrick Industries, Inc. Declares Quarterly Cash Dividend
-
Daniel W. Schatz, M.D. Now Offering patients the Hybrid Choice™ Concierge Program from Concierge Choice Physicians
-
We Paint & Renovate Inc. Celebrates 21 Years of Excellence in San Joaquin County
-
Street Dance Meets Mental Health in New Collaboration Between MindClay and Emmy Winner Jon Boogz
-
Aspen Laser Founders Launch Lucium, LLC, Introducing Patented/ Patent Pending Optical Clearing Technology to Dramatically Improve Laser Therapy Outcomes
-
Marshall Livehouse Bangkok opens: A new home for music and culture in Southeast Asia
-
Columbia Banking System Announces $0.36 Per Common Share Dividend
-
CNRC Reports Q2 2025 Financials Period Ending June 30, 2025; Provides Shareholder Update on Portfolio Companies
-
Atlantic Natural Food Confirms Completion of Sale of Loma Linda Shelf Stable Plant Based Foods Business Unit
-
Vegas Tourism Down 11%--But Mob Story Books Bring Back the High-Rolling Heyday
-
Curtarra Unveils Tom Durable Scratch Resistant Sheer Curtains, a Revolutionary Solution for Pet-Friendly Homes
-
With "The DePauw Promise," the University Reaches an Important Milestone
-
New West Technologies Announces PayFusion365 for Moneris Software Release
-
Origin Agritech Hosts Industry Summit in Zhengzhou, Strengthens Distribution Network with Over 700 Partners
-
Immutable and Ubisoft to Debut Might & Magic Fates at Gamescom 2025
-
The Vistria Group Adds Dr. Janice Jackson as Executive in Residence
-
Postal Advocate Appoints Doug Johnson as VP of Sales & Business Development to Drive Strategic Growth
-
Triojection® from SpinaFX Granted Breakthrough Device Designation by U.S. FDA for Minimally Invasive Lumbar Disc Treatment
-
MRO Recognized on the 2025 Inc. 5000 Annual List for Tenth Year
-
PepsiCo Announces Timing and Availability of Third-Quarter 2025 Financial Results
-
ezCheckPrinting Supports Unlimited Draft, Vendor and Miscellaneous Checks for One Flat Rate
-
Economic Recovery Center Finds New Home at Remote Workspace & Reading Lounge - Reminds Community to Prepare for Hurricane Season
-
Heron Therapeutics, Inc. Adopts Tax Benefits Preservation Plan to Protect NOL Assets and Shareholder Value
-
Jones Soda Reports Second Quarter 2025 Results
-
NexPoint Capital, Inc. Announces Tender Offer for Common Stock
-
Go!Foton showcases optical portfolio and know-how at BICSI Beyond 2025
-
Ameren donates $4 million in energy assistance to agencies across Missouri and Illinois
-
Shasta Pools Introduces New Fiberglass Pool Option for Phoenix-Area Homeowners
-
Asia Pacific Petroleum Conference (APPEC) to Address Key Industry Issues Facing Global Energy Markets
-
TAYLOR DEVICES ANNOUNCES RECORD HIGH FOURTH QUARTER AND FULL YEAR SALES AND PROFIT FOR FISCAL YEAR 2025
-
GDS Wealth Management Named to Inc. 5000 List for Second Consecutive Year
-
NRS's Shallow Basket Energy Project Brings Renewable Energy to Jicarilla Apache Nation, Building on Legacy of Environmental Stewardship
-
Keeper Security Survey at Black Hat USA 2025 Reveals Identity Security Gaps as AI Threats Accelerate
-
Chuck E. Cheese Debuts Spanish and Arabic Music Release, AI-Powered ChuckBot and Content for Fans Around the World
-
Make It to Home Plate with Beef
-
FLOWERS FOODS, INC. REPORTS SECOND QUARTER 2025 RESULTS
-
Kestrel Group Announces 2025 Second Quarter Financial Results
-
YPTC Brings Nonprofit Accounting Services to the Pacific Northwest
-
Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis
-
OLD REPUBLIC DECLARES THIRD QUARTER REGULAR CASH DIVIDEND OF 29 CENTS PER SHARE
-
Galaxy Closes $1.4 Billion Project Financing Facility to Accelerate Helios AI Datacenter Development
-
Novel Gene Therapy for ALS cleared for global trials in China and the U.S.
-
Red 6 Secures U.S. Air Force Contract to Revolutionize F-16 Pilot Training with World-First Augmented Reality Training System
-
First Leveraged ETFs on MDB and LRCX Set to Trade Next Week
-
The All-New Cheddar Bacon Cheese Slider Highlights a New Variety Pack Available in Walmart Stores Nationwide
